What if the future of weight-loss drugs didn’t involve needles at all? Drugmakers are testing once-a-day pills and next-gen GLP-1 injectables that could be easier to use, cheaper to distribute and available to far more people. One expert we spoke with said this could be a “Henry Ford moment” for obesity treatment — with potential benefits beyond weight loss, including improvements in inflammation and metabolic health. Business of Medicine reporter explains what this could mean for patients. Subscribe to The Washington Post on YouTube: https://wapo.st/2QOdcqK

See Full Page